Mayo Clinic News Network

News Resources

Items tagged as "Dr. Andre Terzic"

CHART2: Mayo Clinic Radio Health Minute

In this Mayo Clinic Radio Health Minute, Dr. Andre Terzic comments on the growing impact of regenerative medicine. To listen, click the link below. CHART2

Created by Joel Streed

Mayo Scientist Receives American Heart Association 2014 Basic Research Prize

Mayo Scientist Receives American Heart Association 2014 Basic Research Prize

ROCHESTER, Minn. —The American Heart Association (AHA) awarded the 2014 Basic Research Prize to Andre Terzic, M.D., Ph.D., of Mayo Clinic. The award, presented at the annual meeting of the American Heart Association in Chicago, recognizes outstanding contributions to the advancement of cardiovascular science. Dr. Terzic was commended for pioneering applications [...]

Created by Jennifer Schutz

Mayo Clinic restituye el ritmo cardiaco alterado con intervención regenerativa

ROCHESTER, Minnesota - 3 de septiembre de 2013.  Investigadores de Mayo Clinic han encontrado la manera de resincronizar los movimientos cardiacos después de un ataque al corazón mediante el uso de células madre. Los científicos implantaron células madre modificadas genéticamente, también conocidas como células madre pluripotentes inducidas (iPS, por sus siglas en inglés), en los sectores afectados [...]

Created by Soledad Andrade

Células madre cardiopoyéticas e "inteligentes" ofrecen esperanza a pacientes con insuficiencia cardíaca

ROCHESTER, Minnesota — 10 de abril de 2013.  Con la traducción de un descubrimiento de Mayo Clinic sobre las células madre, un equipo internacional demostró que la terapia con cardiopoyesis (o sea dirigida de forma cardiogénica) o de células madre "inteligentes" puede mejorar la salud de quienes padecen insuficiencia cardíaca. [...]

Created by Emily Hiatt

Mayo Clinic Discovery Leads to FDA Approval for Stem Cell Trial for Heart Failure Patients

U.S. FDA Approves Phase III Cardiopoietic Stem Cell Trial for Heart Failure Patients Based on a Mayo Discovery Cardio3 BioSciences, an international Mayo Clinic collaborator, has received FDA approval for a phase III pivotal clinical trial of its stem cell therapy. The trial will test the Mayo Clinic discovery of cardiopoietic [...]

Created by Dennis Douda

CHART 2 Trial - News Conference Broll (1:42)

Broll of the news conference announcing the CHART 2 trial.

Created by Joel Streed

CHART 2 Trial Dr. Homsy - Explains The Trial (:30)

Dr. Christian Homsy, with Cardio 3 Biosciences explains today's announcement and a little about the trial.

Created by Joel Streed

Chart 2 Trial Dr. Terzic - Future Promise of Regenerative Medicine (:15)

Mayo Clinic Dr. Andre Terzic gives his thoughts on the promise that is held in regenerative medicine.

Created by Joel Streed

Load More